发明名称 Adaptive confirmation of treatable arrhythmia in implantable cardiac stimulus devices
摘要 Methods and devices for adjusting therapy delivery decisions in an implantable cardiac stimulus device by observing cardiac activity following an initial identification of a treatable condition. In some examples, cardiac activity that appears benign is quantified and a therapy confirmation threshold is adjusted according to how much apparently benign cardiac activity is seen after an initial identification of a treatable condition. In other examples, a new threshold is applied following the initial identification of treatable condition, removing historical data preceding the initial identification from subsequent therapy delivery decisions.
申请公布号 US9149637(B2) 申请公布日期 2015.10.06
申请号 US201012826241 申请日期 2010.06.29
申请人 CAMERON HEALTH, INC. 发明人 Warren Jay A.;Sanghera Rick;Allavatam Venugopal
分类号 A61N1/39;A61N1/365;A61N1/362;A61B5/0464 主分类号 A61N1/39
代理机构 Seager, Tufte & Wickhem LLP 代理人 Seager, Tufte & Wickhem LLP
主权项 1. A method of operation in an implantable cardiac stimulus device (ICSD) comprising a housing that contains a battery power source and operational circuitry that operates by analyzing cardiac signals from implanted electrode(s) in order to determine whether a treatable arrhythmia is detected, the method comprising: the ICSD making an initial determination that a treatable cardiac arrhythmia is occurring; the ICSD preparing to deliver therapy in response to the initial determination and, while preparing to deliver therapy, observing whether indications of benign cardiac rhythm are detected; when the ICSD is prepared to deliver therapy, applying Confirmation criteria to confirm the treatable cardiac arrhythmia is ongoing, the Confirmation criteria comprising a Therapy threshold and the Confirmation criteria is applied by: counting intervals between events detected from sensed cardiac signals that are shorter than a short interval threshold to generate a Short Interval Count (SIC); andcomparing SIC to the Therapy threshold; and if the Confirmation criteria are met, delivering therapy from the ICSD; wherein the method comprises the ICSD changing the Confirmation criteria in response to identification of one or more of the indications of benign cardiac rhythm while the ICSD is preparing to deliver therapy by increasing the Therapy threshold to require a larger SIC value; further wherein the Confirmation criteria are actively updated and re-applied until either therapy is delivered or the ICSD determines that therapy is not needed; further wherein; the ICSD uses an event detection method in which events are detected from sensed cardiac signals, and intervals between the detected events are used to estimate cardiac rate for use in the initial determination that a treatable cardiac arrhythmia is occurring.
地址 St. Paul MN US
您可能感兴趣的专利